South Africa SAHPRA Medical Device Establishment Licenses (3,000 Active)
An in-depth analysis of 3,000 active SAHPRA establishment licenses, examining the balance of distributors, wholesalers, manufacturers, and municipal hubs.
Executive Summary & Direct Answer
For medical device manufacturers planning commercial expansion in Sub-Saharan Africa, South Africa serves as the primary gateway. However, before any medical device or In Vitro Diagnostic (IVD) can be legally imported, distributed, or sold in the country, the economic operators involved must hold a valid establishment license. These licenses are regulated and issued by the South African Health Products Regulatory Authority (SAHPRA).
To provide medtech executives, regulatory affairs directors, and market access teams with clear market intelligence, this analysis reviews the complete dataset of SAHPRA-licensed medical device establishments.
Based on a detailed analysis of the 3,000 active medical device establishment licenses in SAHPRA's register, several key trends emerge:
- Distributors Form the Market Backbone: The landscape is dominated by Distributors, which account for 49.87% (1,496 licenses) of all active establishments. Wholesalers make up 26.60% (798 licenses), and Manufacturers represent 23.53% (706 licenses).
- Pretoria and Johannesburg Lead as Regional Hubs: The administrative and commercial capital cities of Gauteng, Pretoria and Johannesburg, are the dominant clusters for medical device operations, each holding 12.77% (383 licenses) of the market. Cape Town represents the third-largest cluster with 8.77% (263 licenses).
- Regulatory Modernization Peak in 2025: The number of new establishment licenses issued peaked in 2025 with 777 licenses, representing a significant regulatory enforcement push by SAHPRA to bring more operators into formal compliance post-pandemic.
This post details these statistics and outlines the compliance requirements for foreign manufacturers seeking to select a local distribution partner or establish a local entity in South Africa.
Regulatory Background: Establishing the Legal Framework
In South Africa, the licensing of medical device economic operators is governed by the Medicines and Related Substances Act, 1965 (Act 101 of 1965), specifically Section 22C(1)(b). Under this legislation, no person may manufacture, import, export, act as a wholesaler of, or distribute any medical device or IVD without a license from SAHPRA.
The regulatory framework distinguishes clearly between product registration and establishment licensing:
- Establishment Licensing (MDEL): Focuses on the entity (the company, its facilities, its staff, and its quality systems). An MDEL is a prerequisite for any company that wants to import, distribute, wholesale, or manufacture medical devices.
- Product Registration: Focuses on the specific medical device or IVD itself, verifying its safety, performance, and clinical efficacy.
Understanding the establishment licensing landscape is crucial for foreign manufacturers because the type of license held by your local partner determines their legal capacity. For example, a local partner holding only a "Wholesaler" license cannot legally act as your importer of record. To understand the broader product pathway, refer to our SAHPRA medical device registration guide.
Distribution of Establishment License Types
The division of establishment licenses among manufacturers, distributors, and wholesalers offers a direct view of the structure of South Africa's medical device supply chain.
| License Type | Primary Authorized Activities | Active Licenses | Percentage of Registry |
|---|---|---|---|
| Distributor | Import, export, and distribute medical devices or IVDs | 1,496 | 49.87% |
| Wholesaler | Local storage, transport, and delivery (no direct import/export) | 798 | 26.60% |
| Manufacturer | Design, manufacture, assemble, pack, label, import, export | 706 | 23.53% |
| Total | 3,000 | 100.00% |
pie title SAHPRA Establishment Licenses by Type
"Distributor" : 1496
"Wholesaler" : 798
"Manufacturer" : 706
(Note: The above diagram illustrates the distribution of SAHPRA establishment licenses by type.)
1. The Dominance of Distributors (49.87%)
Distributors make up nearly half of the licensed economic operators. This high concentration highlights the import-reliant nature of the South African healthcare market. Because South Africa imports over 85% of its medical devices and advanced health technologies, international manufacturers rely on these 1,496 licensed distributors to manage the customs clearance, local logistics, and sales representation of their products.
A licensed distributor is authorized by SAHPRA to:
- Import medical devices from overseas manufacturers.
- Export medical devices to other regional markets (such as Namibia, Botswana, or Zimbabwe).
- Sell and distribute devices directly to public and private hospitals, clinics, and laboratories.
2. The Role of Wholesalers (26.60%)
Wholesalers hold 798 licenses in the registry. Unlike distributors, wholesalers are not authorized to import medical devices directly from foreign countries. Instead, they buy their stock from locally licensed manufacturers or distributors and distribute it to local retailers, pharmacies, or medical centers.
For a foreign manufacturer, partnering directly with a company that only holds a Wholesaler license is a regulatory dead end for initial market entry, as they cannot legally manage your customs clearance or act as your initial importer.
3. The Local Manufacturing Segment (23.53%)
At first glance, 706 licensed manufacturers suggest a robust local production sector. However, a deeper examination of the registry reveals that many entities holding a "Manufacturer" license are engaged in secondary manufacturing activities rather than primary design and fabrication. Under SAHPRA guidelines, activities that qualify for a manufacturing license include:
- Repackaging and relabeling imported bulk products.
- Assembling medical kits or trays (such as surgical prep packs or dental trays) containing imported components.
- Refurbishing or remanufacturing capital medical equipment.
- Sterilizing finished devices.
True primary manufacturing of high-risk medical devices (Class C and D, such as active implants or complex diagnostics) remains limited in South Africa, with local production focused primarily on Class A and B consumables, orthopedic orthotics, and basic wound care products.
Regional Clusters: Where is South Africa's Medtech Industry Located?
The geographic distribution of SAHPRA establishment licenses reveals clear industrial clusters. Medical device operators are concentrated around the primary economic and political centers of the country.
Our analysis of the company addresses within the SAHPRA registry highlights the top municipal clusters:
| Region / City | Active Licenses | Percentage of Total | Industrial Focus |
|---|---|---|---|
| Pretoria | 383 | 12.77% | Regulatory offices, government affairs, public tender representation |
| Johannesburg | 383 | 12.77% | Corporate headquarters, logistics warehouses, commercial distribution |
| Cape Town | 263 | 8.77% | Biotech start-ups, R&D labs, specialized manufacturing, medical software |
| Other Regions | 1,971 | 65.70% | Regional sales offices, local pharmacies, sub-distributors |
| Total | 3,000 | 100.00% |
(Note: City counts reflect the city name appearing in the registered company address. Johannesburg's 383 figure covers the central city; major northern suburbs such as Sandton, Midrand, and Randburg — where many medtech firms are headquartered — are counted under "Other Regions," so the broader Johannesburg metropolitan total is higher than the central-city count shown here.)
The Gauteng Super-Cluster: Pretoria and Johannesburg
Pretoria (383 licenses) and Johannesburg (383 licenses) are physically adjacent in the Gauteng province, effectively forming a single medtech hub that accounts for more than 25% of all active licenses in South Africa.
- Pretoria's dominance is driven by its status as the administrative capital. It houses SAHPRA’s head offices and the National Department of Health, making it the preferred location for regulatory consulting firms, tender compliance specialists, and primary importers who interact regularly with government officials.
- Johannesburg is the financial and logistical heart of the country. Major international medical device companies (such as Medtronic, Johnson & Johnson, and Becton Dickinson) locate their primary warehouses and commercial operations here to leverage OR Tambo International Airport and the province's extensive distribution networks into the rest of the Southern African Development Community (SADC).
The Western Cape Hub: Cape Town
Cape Town (263 licenses) is developing a distinct identity focused on medtech innovation, medical software development, and specialized manufacturing. The Western Cape provincial government actively supports biotech incubators, making it a hub for start-ups specializing in digital health, point-of-care diagnostics, and local manufacturing of niche devices.
Historical Growth: Analyzing Licensing Timelines
Tracking the year of license issuance (parsed from each licence's original issue date) reveals SAHPRA's regulatory enforcement timeline. The establishment licensing database shows a clear acceleration in activity over the last few years:
- 2017: 103 new licenses
- 2018: 110 new licenses
- 2019: 127 new licenses
- 2020: 90 new licenses
- 2021: 235 new licenses
- 2022: 225 new licenses
- 2023: 482 new licenses
- 2024: 642 new licenses
- 2025: 777 new licenses (Peak Year)
- 2026 (partial, through mid-June): 201 new licenses
(Note: 2,992 of the 3,000 licences carry a parseable original-issue date; eight records leave the issue date blank and are excluded from the year breakdown.)
Drivers Behind the 2025 Licensing Surge
The peak in 2025, during which 777 new licenses were issued, was driven by three primary factors:
- Phased Rollout of Mandatory ISO 13485: In April 2025, SAHPRA announced a phased requirement that manufacturers and distributors (importers) hold a valid ISO 13485:2016 certificate from a SAHPRA-recognized conformity assessment body. The requirement became mandatory when renewing an establishment licence from June 1, 2025, with SAHPRA set to verify compliance across all licence holders by April 1, 2028. This pushed many operators to formalize — or renew — their licences and quality systems during 2025.
- Public Procurement Compliance: The South African government’s public health procurement system requires that any distributor bidding for state hospital supply contracts present a valid, active SAHPRA establishment license. This commercial requirement prompted a wave of applications from local distributors.
- SAHPRA Backlog Clearance: Following internal digital upgrades and the recruitment of additional review staff, SAHPRA cleared a substantial backlog of pending applications that had accumulated since 2022.
Key Requirements for Obtaining a SAHPRA Establishment License
For companies planning to establish a local footprint in South Africa or evaluating the compliance of their local partners, SAHPRA mandates strict operational gates:
1. The Authorised Representative (AR)
Every licensed establishment must designate an Authorised Representative. The AR must be a natural person who is resident in South Africa and legally responsible for ensuring the company’s compliance with Act 101 of 1965. The AR’s responsibilities include:
- Acting as the primary point of contact for SAHPRA.
- Verifying that all medical devices imported or distributed by the company are registered or listed.
- Managing post-market surveillance, adverse event reporting, and recall actions.
- Ensuring the company’s staff are trained on quality and storage procedures.
2. Implementation of a Quality Management System (QMS)
SAHPRA requires all applicants for a Manufacturer or Distributor license to implement and maintain a QMS.
- ISO 13485 Certification: The QMS must be aligned with ISO 13485. For distributors of Class B, C, and D devices, formal ISO 13485 certification from a SAHPRA-recognized certification body (such as a registrar accredited by SANAS or an international equivalent) is mandatory.
- Site Master File (SMF) or Quality Manual: The applicant must submit a detailed description of their facility’s storage conditions (temperature controls, pest management, security), product trace-ability, complaint handling, and quarantine protocols for non-conforming products.
3. Record Keeping and Traceability
Licensed establishments must maintain detailed records of all medical devices they handle, ensuring complete traceability from the foreign manufacturer to the end-user (hospital or clinic). These records must be kept for a minimum of 5 years and are subject to unannounced audits by SAHPRA inspectors.
Strategic Guidelines for Foreign Manufacturers
When expanding your medical device business in South Africa, consider the following commercial and regulatory strategies:
1. Verify Your Partner's License Scope
Before signing a distribution agreement, request a copy of your partner's SAHPRA establishment license and verify its status on the official registry. Ensure that:
- The license status is active.
- The license type is "Distributor" or "Manufacturer" (not just "Wholesaler").
- The license scope includes the specific risk classes of your devices (Class A, B, C, or D).
2. Mitigate Channel Lock-In Risks
In South Africa, the establishment license holder is responsible for product listings. If you grant exclusive distribution and regulatory representation to a single distributor, you are vulnerable to channel lock-in. If you need to change distributors due to underperformance, transferring the regulatory rights can be difficult if the distributor refuses to cooperate.
Consider appointing an independent regulatory consultant or a professional third-party license holder in Pretoria or Johannesburg to hold your product registrations, while licensing multiple commercial distributors to manage sales and logistics.
3. Plan for Long Lead Times
While SAHPRA has modernized its processes, obtaining a new establishment license still takes 6 to 8 months on average, depending on QMS preparation and inspection scheduling. Factor these timelines into your market-entry schedules and launch budgets.
License Type Decision Matrix: Choosing the Right Establishment Role
The 49.87% distributor / 26.60% wholesaler / 23.53% manufacturer split maps directly onto the business models a foreign manufacturer can adopt in South Africa. Use this matrix to match your intended commercial role to the correct SAHPRA license type before signing partner agreements.
| Your Intended Role in South Africa | License Type Required | Can Import Directly? | Typical Use Case |
|---|---|---|---|
| Launch and sell an imported device you do not manufacture | Distributor | Yes | Foreign manufacturer appointing a local importer-distributor |
| Store and onward-ship devices sourced from a local distributor or manufacturer | Wholesaler | No | Regional logistics hub, hospital-supply wholesaler |
| Manufacture, assemble, repackage, or relabel devices locally | Manufacturer | Yes (for own-made products) | Local production, kitting, refurbishment, sterilization |
| Hold registrations for multiple products while others handle distribution | Distributor (often paired with an independent regulatory consultant) | Yes | Separating regulatory ownership from commercial sales |
A common compliance trap is partnering with a company that holds only a Wholesaler license and assuming it can act as the importer of record. Under Section 22C(1)(b) of the Medicines and Related Substances Act 101 of 1965, only a licensed Distributor or Manufacturer may import medical devices; a Wholesaler may move product only after it has already cleared customs under another entity's import authority. Confirm your partner's exact license type on the SAHPRA register before structuring the commercial relationship.
Establishment Licensing Versus Product Registration
It is worth restating the distinction, because the two are frequently confused. Establishment licensing authorizes a company to operate in the medical device supply chain — manufacturing, importing, wholesaling, or distributing — and focuses on the entity, its facilities, its Authorised Representative, and its quality system. Product registration (or listing) evaluates a specific device's safety, performance, and classification. A company can hold a valid establishment license even while the devices it handles are still progressing through the separate product-registration or listing process. The 3,000-licence landscape analyzed here describes the establishment layer only; it does not count approved products.
Frequently Asked Questions (FAQ)
How many active licensed medical device establishments are there in South Africa?
As of June 2026, SAHPRA's register contains 3,000 active medical device establishment licenses, covering manufacturers, distributors, and wholesalers.
What is the difference between a Distributor and a Wholesaler license under SAHPRA?
A licensed Distributor is authorized to import medical devices directly from international manufacturers, export them, and distribute them to end-users. A licensed Wholesaler can only procure medical devices locally from licensed domestic manufacturers or distributors and distribute them within South Africa; they are not authorized to import.
Is ISO 13485 certification mandatory for a SAHPRA establishment license?
Yes, for manufacturers and distributors of Class B, C, and D medical devices and IVDs, having an ISO 13485 certified Quality Management System is a mandatory requirement. Certain Class A (low-risk) operators may be exempt or subject to simplified QMS requirements.
Where are most medical device companies in South Africa located?
The majority of medtech companies are located in the Gauteng province, with Pretoria (383 licenses) and Johannesburg (383 licenses) forming the main hub. Cape Town in the Western Cape is the third-largest cluster with 263 licenses.
Can a single company hold more than one type of SAHPRA establishment license?
Yes. A company may hold multiple license types — for example, both a Manufacturer license for its own locally made products and a Distributor license for imported lines it brings in. Each activity still requires its own license, its own Authorised Representative coverage, and its own quality-system evidence. The license-type counts in this analysis reflect individual licenses issued, so a company holding more than one license can appear more than once across the totals.
How often must a SAHPRA establishment license be renewed?
SAHPRA establishment licenses are renewed periodically, and renewal is now the key enforcement point for the new ISO 13485:2016 requirement: from June 1, 2025, manufacturers and distributors (importers) must present a valid ISO 13485:2016 certificate from a SAHPRA-recognized conformity assessment body when renewing. Planning a QMS audit ahead of the renewal window is therefore essential to avoid a lapse that would suspend import and distribution rights.
Does holding a SAHPRA establishment license alone allow me to sell any device?
No. An establishment license authorizes a company to operate in a given supply-chain role (manufacturing, importing, wholesaling, or distributing), but each device the company handles must also be appropriately registered or listed with SAHPRA, and the device's risk class must fall within the scope the establishment is set up to handle. A new establishment entering the market therefore needs both layers in place — the entity-level license and the product-level registration or listing — before commercial activity can begin. This two-layer structure is also why the establishment-license landscape analyzed here looks so different from any future product-registration analysis.
Conclusion & Legal Disclaimer
Navigating South Africa's medical device market requires a clear understanding of SAHPRA's establishment licensing system. The dominance of distributors in the registry highlights the country's reliance on imports, while the concentration of licenses in Pretoria and Johannesburg underscores the regional nature of the market. Foreign manufacturers must carefully verify their partners' license status and scope to ensure compliance and maintain commercial flexibility. The 2025 licensing surge — peaking at 777 new establishment licenses and coinciding with the rollout of mandatory ISO 13485:2016 certification at renewal — signals that SAHPRA is tightening quality expectations, so the cost and lead time of bringing a partner into (or keeping them in) formal compliance is now a material factor in any South African market-access plan.
Disclaimer: This analysis is based on public register data from the South African Health Products Regulatory Authority (SAHPRA) as of June 2026. The information provided in this article is for educational and market intelligence purposes only and does not constitute legal, regulatory, or quality-system advice for any specific product or organization. For specific regulatory filings, consult with a qualified regulatory affairs professional or your local representative in South Africa.
Sources
- Medicines and Related Substances Act, 1965 (Act 101 of 1965): Government of South Africa.
- SAHPRA Medical Device Licences Issued Register: South African Health Products Regulatory Authority (SAHPRA).
- SAHPRA Guidelines for Medical Device Establishment Licensing: SAHPRA Official Portal.
- South African Medical Device Industry Association (SAMED): Industry guidelines and market overview SAMED Official Portal.
- International Trade Administration (ITA) South Africa Commercial Guide: U.S. Department of Commerce.